Nificant predictors of MetS independent of adiponectin and leptin (Table 3). Previous

Nificant predictors of MetS independent of adiponectin and leptin (Table 3). Previous studies have found that low E2 was associated with obesity and MetS in productive females with PCO, and adult males with the aromatase gene mutation. [17,18,19,29,31,40,41,42,43]. In our study, we also found that low E2 was MedChemExpress Fexinidazole significantly associated with MetS in middle-aged males. This is in contrast to findings reported by Maggio et al that found an independent association of increased E2 with MetS in an elderly male population [44]. Therefore, E2 might have contrary influences on MetS in middle-aged and elderly male populations. The result of low E2 with MetS in our study is consistent with theTable 2. Means 6 standard deviations of the clinical characteristics and biochemical variables in subjects with various numbers of metabolic syndrome (MetS) components.Subjects without MetS Numbers of MetS Components Age (yrs) BMI (Kg/m ) Adiponectin (ng/ml) Leptin (ng/ml) E2 (pg/ml) 1,25(OH)2D3 (pg/ml)Subjects with MetS 2 (n = 134) 55.364.6 25.162.aP value5 (n = 22) 57.366.2ab 28.962.abc0 (n = 95) 54.863.0 23.362.1 16.868.3 2.761.4 26.068.4 45.4616.1 (n = 183) 55.163.0 24.362.1 14.766.6a 3.261.6a 26.967.6 49.3621.3 (n = 139) 56.365.2ab 26.262.ab4 (n = 82) 57.366.7abc 29.6615.abc,0.001* ,0.001* ,0.001* ,0.001* ,0.001* ,0.001*12.065.5ab 3.862.3ab 26.068.8 47.3618.8.464.6abc 4.762.3abc 19.669.1abc 43.1616.3b7.264.2abc 6.163.2abcd 19.869.4abc 37.8615.4abcd5.663.1abcd 6.361.9abcd 19.7610.0abc 35.1615.8abcBMI: body mass index; E2: estradiol; *: Significant difference (P,0.05); a P,0.05 as compared to the subjects without MetS components; b P,0.05 as compared to subjects with one of the MetS components; c P,0.05 as compared to subjects with two of the MetS components; d P,0.05 as compared to subjects with three of the MetS components; e P,0.05 as compared to subjects with four of the MetS components. doi:10.1371/journal.pone.0060295.tLow Estradiol and Metabolic SyndromeTable 3. Multivariate regression analyses for the associations of circulating adiponectin, E2, leptin, 1,25(OH)2D3 levels and metabolic syndrome (MetS).Variablesb (standardized coefficient) SEt95 Confidence Interval (CI)P-valueModel 1: adjustment for age, BMI, and personal habits (smoking, alcohol drinking and betel quid chewing) Adiponectin E2 Leptin 1,25(OH)2D3 20.421 20.321 0.111 20.153 0.002 0.002 0.001 0.001 212.510 29.243 3.069 24.172 (20.034,20.025) (20.021,20.014) (0.001,0.006) (20.006,0.002) ,0.001* ,0.001* 0.002* ,0.001*(B) Model 2: adjustment for age, BMI, personal habits (smoking, alcohol drinking and betel quid chewing), SHBG and all of above 4 factors (adiponectin, E2, leptin, and 1,25(OH)2D3 levels)( R2 = 0.438). Adiponectin E2 Leptin 1,25(OH)2D3 20.259 20.216 0.086 20.067 0.003 0.002 0.001 0.001 27.054 26.397 2.335 22.010 (20.023,20.013) (20.015,20.008) (0.001,0.005) (20.003,0.000) ,0.001* ,0.001* 0.007* 0.BMI: body mass index; E2: estradiol; SHBG: sex hormone inding globulin; *: Significant difference (P,0.05). doi:10.1371/journal.pone.0060295.tlow estradiol-to-testosterone ratio seen in polycystic ovary syndrome with MetS, which is also associated with oligoanovulatory SC 66 price cycles, atherogenic lipidic pattern, and insulin resistance [17,18,19,45]. E2 and its receptor play important physiological and protective roles in the reproductive ages of both males and females. For males, E2 acts to prevent apoptosis of sperm cells [46] and works in vascular protection and modulation of inflammation.Nificant predictors of MetS independent of adiponectin and leptin (Table 3). Previous studies have found that low E2 was associated with obesity and MetS in productive females with PCO, and adult males with the aromatase gene mutation. [17,18,19,29,31,40,41,42,43]. In our study, we also found that low E2 was significantly associated with MetS in middle-aged males. This is in contrast to findings reported by Maggio et al that found an independent association of increased E2 with MetS in an elderly male population [44]. Therefore, E2 might have contrary influences on MetS in middle-aged and elderly male populations. The result of low E2 with MetS in our study is consistent with theTable 2. Means 6 standard deviations of the clinical characteristics and biochemical variables in subjects with various numbers of metabolic syndrome (MetS) components.Subjects without MetS Numbers of MetS Components Age (yrs) BMI (Kg/m ) Adiponectin (ng/ml) Leptin (ng/ml) E2 (pg/ml) 1,25(OH)2D3 (pg/ml)Subjects with MetS 2 (n = 134) 55.364.6 25.162.aP value5 (n = 22) 57.366.2ab 28.962.abc0 (n = 95) 54.863.0 23.362.1 16.868.3 2.761.4 26.068.4 45.4616.1 (n = 183) 55.163.0 24.362.1 14.766.6a 3.261.6a 26.967.6 49.3621.3 (n = 139) 56.365.2ab 26.262.ab4 (n = 82) 57.366.7abc 29.6615.abc,0.001* ,0.001* ,0.001* ,0.001* ,0.001* ,0.001*12.065.5ab 3.862.3ab 26.068.8 47.3618.8.464.6abc 4.762.3abc 19.669.1abc 43.1616.3b7.264.2abc 6.163.2abcd 19.869.4abc 37.8615.4abcd5.663.1abcd 6.361.9abcd 19.7610.0abc 35.1615.8abcBMI: body mass index; E2: estradiol; *: Significant difference (P,0.05); a P,0.05 as compared to the subjects without MetS components; b P,0.05 as compared to subjects with one of the MetS components; c P,0.05 as compared to subjects with two of the MetS components; d P,0.05 as compared to subjects with three of the MetS components; e P,0.05 as compared to subjects with four of the MetS components. doi:10.1371/journal.pone.0060295.tLow Estradiol and Metabolic SyndromeTable 3. Multivariate regression analyses for the associations of circulating adiponectin, E2, leptin, 1,25(OH)2D3 levels and metabolic syndrome (MetS).Variablesb (standardized coefficient) SEt95 Confidence Interval (CI)P-valueModel 1: adjustment for age, BMI, and personal habits (smoking, alcohol drinking and betel quid chewing) Adiponectin E2 Leptin 1,25(OH)2D3 20.421 20.321 0.111 20.153 0.002 0.002 0.001 0.001 212.510 29.243 3.069 24.172 (20.034,20.025) (20.021,20.014) (0.001,0.006) (20.006,0.002) ,0.001* ,0.001* 0.002* ,0.001*(B) Model 2: adjustment for age, BMI, personal habits (smoking, alcohol drinking and betel quid chewing), SHBG and all of above 4 factors (adiponectin, E2, leptin, and 1,25(OH)2D3 levels)( R2 = 0.438). Adiponectin E2 Leptin 1,25(OH)2D3 20.259 20.216 0.086 20.067 0.003 0.002 0.001 0.001 27.054 26.397 2.335 22.010 (20.023,20.013) (20.015,20.008) (0.001,0.005) (20.003,0.000) ,0.001* ,0.001* 0.007* 0.BMI: body mass index; E2: estradiol; SHBG: sex hormone inding globulin; *: Significant difference (P,0.05). doi:10.1371/journal.pone.0060295.tlow estradiol-to-testosterone ratio seen in polycystic ovary syndrome with MetS, which is also associated with oligoanovulatory cycles, atherogenic lipidic pattern, and insulin resistance [17,18,19,45]. E2 and its receptor play important physiological and protective roles in the reproductive ages of both males and females. For males, E2 acts to prevent apoptosis of sperm cells [46] and works in vascular protection and modulation of inflammation.